Ontology type: schema:ScholarlyArticle
2019-04-03
AUTHORSSatoshi Tokimasa, Hideki Kitahara, Takashi Nakayama, Yoshihide Fujimoto, Taiki Shiba, Nobuaki Shikama, Mizuo Nameki, Toshiharu Himi, Ken-Ichi Fukushima, Yoshio Kobayashi
ABSTRACTAlthough it has been reported that prasugrel achieves stronger antiplatelet effect and fewer cardiovascular events compared to clopidogrel in Japanese patients, there are limited data comparing the safety between the 2 dose regimens. Data from 1031 consecutive patients with coronary artery disease undergoing PCI at 5 institutions from May 2014 to April 2016, who received aspirin plus either clopidogrel (619 patients) or prasugrel (412 patients), were retrospectively analyzed. The choice of clopidogrel or prasugrel was left to the operator's discretion. Adverse events were defined as a composite of bleeding, hepatopathy, leukopenia, thrombopenia, exanthema, and major adverse cardiovascular events (MACE). MACE was defined as a composite of cardiovascular death, nonfatal myocardial infarction, and nonfatal ischemic stroke. The average follow-up period was 143 days in the prasugrel group and 263 days in the clopidogrel group. Adverse events occurred in 34.5% of patients in the prasugrel group and in 28.6% in the clopidogrel group. Although the Kaplan-Meier curves showed lower survival rates from MACE, all-bleeding, major bleeding, minor bleeding, and adverse events, in the prasugrel group compared to the clopidogrel group (log rank test p = 0.009, p = 0.001, p = 0.012, p = 0.018, and p < 0.001, respectively), multivariate Cox-regression analyses determined prasugrel as a significant risk factor for all-bleeding, minor bleeding, and adverse events, but not for MACE and major bleeding events. Dual antiplatelet therapy with prasugrel was independently associated with minor bleeding events, but not with MACE and major bleeding events, compared to clopidogrel, after PCI in common clinical settings. More... »
http://scigraph.springernature.com/pub.10.1007/s00380-019-01395-0
DOIhttp://dx.doi.org/10.1007/s00380-019-01395-0
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1113182343
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/30944971
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Cardiorespiratory Medicine and Haematology",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Chiba University",
"id": "https://www.grid.ac/institutes/grid.136304.3",
"name": [
"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan. YFD02270@nifty.com."
],
"type": "Organization"
},
"familyName": "Tokimasa",
"givenName": "Satoshi",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Chiba University",
"id": "https://www.grid.ac/institutes/grid.136304.3",
"name": [
"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan."
],
"type": "Organization"
},
"familyName": "Kitahara",
"givenName": "Hideki",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Chiba University",
"id": "https://www.grid.ac/institutes/grid.136304.3",
"name": [
"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan."
],
"type": "Organization"
},
"familyName": "Nakayama",
"givenName": "Takashi",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Chiba University",
"id": "https://www.grid.ac/institutes/grid.136304.3",
"name": [
"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan.",
"Department of Cardiology, Kimitsu Chuo Hospital, Chiba, Japan."
],
"type": "Organization"
},
"familyName": "Fujimoto",
"givenName": "Yoshihide",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Chiba Aoba Municipal Hospital",
"id": "https://www.grid.ac/institutes/grid.459433.c",
"name": [
"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan.",
"Department of Cardiology, Chiba Aoba Municipal Hospital, Chiba, Japan."
],
"type": "Organization"
},
"familyName": "Shiba",
"givenName": "Taiki",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Chiba Aoba Municipal Hospital",
"id": "https://www.grid.ac/institutes/grid.459433.c",
"name": [
"Department of Cardiology, Chiba Aoba Municipal Hospital, Chiba, Japan."
],
"type": "Organization"
},
"familyName": "Shikama",
"givenName": "Nobuaki",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Chiba Kaihin Municipal Hospital",
"id": "https://www.grid.ac/institutes/grid.440399.3",
"name": [
"Department of Cardiology, Chiba Kaihin Municipal Hospital, Chiba, Japan."
],
"type": "Organization"
},
"familyName": "Nameki",
"givenName": "Mizuo",
"type": "Person"
},
{
"affiliation": {
"name": [
"Department of Cardiology, Kimitsu Chuo Hospital, Chiba, Japan."
],
"type": "Organization"
},
"familyName": "Himi",
"givenName": "Toshiharu",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Matsudo City Hospital",
"id": "https://www.grid.ac/institutes/grid.416584.a",
"name": [
"Department of Cardiology, Matsudo City Hospital, Chiba, Japan."
],
"type": "Organization"
},
"familyName": "Fukushima",
"givenName": "Ken-Ichi",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Chiba University",
"id": "https://www.grid.ac/institutes/grid.136304.3",
"name": [
"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan."
],
"type": "Organization"
},
"familyName": "Kobayashi",
"givenName": "Yoshio",
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1056/nejmoa0706482",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000755110"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.clpt.6100139",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006304268",
"https://doi.org/10.1038/sj.clpt.6100139"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.clpt.6100139",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006304268",
"https://doi.org/10.1038/sj.clpt.6100139"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.5551/jat.26013",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006773540"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.jjcc.2015.07.019",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021337484"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.jcin.2012.07.015",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022376062"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12928-016-0452-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022456997",
"https://doi.org/10.1007/s12928-016-0452-7"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12928-016-0452-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022456997",
"https://doi.org/10.1007/s12928-016-0452-7"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1161/circulationaha.110.009449",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1025074445"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/bmt.2012.244",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028358194",
"https://doi.org/10.1038/bmt.2012.244"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.4172/2329-6607.1000162",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1029463679"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/eurheartj/ehu523",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030609453"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1253/circj.cj-14-0266",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031368573"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1124/dmd.105.007989",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038051799"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa0809171",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1039584602"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.jacc.2014.12.046",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049213790"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1253/circj.cj-13-1482",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051285887"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1409312",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051736615"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1160/th13-10-0891",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1063293578"
],
"type": "CreativeWork"
}
],
"datePublished": "2019-04-03",
"datePublishedReg": "2019-04-03",
"description": "Although it has been reported that prasugrel achieves stronger antiplatelet effect and fewer cardiovascular events compared to clopidogrel in Japanese patients, there are limited data comparing the safety between the 2 dose regimens. Data from 1031 consecutive patients with coronary artery disease undergoing PCI at 5 institutions from May 2014 to April 2016, who received aspirin plus either clopidogrel (619 patients) or prasugrel (412 patients), were retrospectively analyzed. The choice of\u00a0clopidogrel or prasugrel was left to the operator's discretion. Adverse events were defined as a composite of bleeding, hepatopathy, leukopenia, thrombopenia, exanthema, and major adverse cardiovascular events (MACE). MACE was defined as a composite of cardiovascular death, nonfatal myocardial infarction, and nonfatal ischemic stroke. The average follow-up period was 143\u00a0days in the prasugrel group and 263\u00a0days in the clopidogrel group. Adverse events occurred in 34.5% of patients in the prasugrel group and in 28.6% in the clopidogrel group. Although the Kaplan-Meier curves showed lower survival rates from MACE, all-bleeding, major bleeding, minor bleeding, and adverse events, in the prasugrel group compared to the clopidogrel group (log rank test p\u2009=\u20090.009, p\u2009=\u20090.001, p\u2009=\u20090.012, p\u2009=\u20090.018, and p\u2009<\u20090.001, respectively), multivariate Cox-regression analyses determined prasugrel as a significant risk factor for all-bleeding, minor bleeding, and adverse events, but not for MACE and major bleeding events. Dual antiplatelet therapy with prasugrel was independently associated with minor bleeding events, but not with MACE and major bleeding events, compared to clopidogrel, after PCI in common clinical settings.",
"genre": "research_article",
"id": "sg:pub.10.1007/s00380-019-01395-0",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1095887",
"issn": [
"0910-8327",
"1615-2573"
],
"name": "Heart and Vessels",
"type": "Periodical"
}
],
"name": "Multicenter research of bleeding risk between prasugrel and clopidogrel in Japanese patients with coronary artery disease undergoing percutaneous coronary intervention.",
"productId": [
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"30944971"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"8511258"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s00380-019-01395-0"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1113182343"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s00380-019-01395-0",
"https://app.dimensions.ai/details/publication/pub.1113182343"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-11T13:59",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130823_00000006.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1007/s00380-019-01395-0"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00380-019-01395-0'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00380-019-01395-0'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00380-019-01395-0'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00380-019-01395-0'
This table displays all metadata directly associated to this object as RDF triples.
179 TRIPLES
20 PREDICATES
41 URIs
16 LITERALS
6 BLANK NODES